Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Development and evaluation of a FACS-based medium-throughput assay for HCV entry inhibitors.

Ziegler S, Kronenberger B, Albrecht BA, Kaul A, Gamer AL, Klein CD, Hartmann RW.

J Biomol Screen. 2009 Jul;14(6):620-6. doi: 10.1177/1087057109337161. Epub 2009 Jun 16.

PMID:
19531666
2.

Structural modifications of salicylates: inhibitors of human CD81-receptor HCV-E2 interaction.

Holzer M, Ziegler S, Neugebauer A, Kronenberger B, Klein CD, Hartmann RW.

Arch Pharm (Weinheim). 2008 Aug;341(8):478-84. doi: 10.1002/ardp.200700261.

PMID:
18618487
3.

Identification of terfenadine as an inhibitor of human CD81-receptor HCV-E2 interaction: synthesis and structure optimization.

Holzer M, Ziegler S, Albrecht B, Kronenberger B, Kaul A, Bartenschlager R, Kattner L, Klein CD, Hartmann RW.

Molecules. 2008 May 7;13(5):1081-110.

4.

Microwave-Assisted Syntheses of Amino Acid Ester Substituted Benzoic Acid Amides: Potential Inhibitors of Human CD81-Receptor HCV-E2 Interaction.

Holzer M, Ziegler S, Kronenberger B, Klein CD, Hartmann RW.

Open Med Chem J. 2008 Apr 15;2:21-5. doi: 10.2174/1874104500802010021.

5.

Whole genome amplification of sodium bisulfite-treated DNA allows the accurate estimate of methylated cytosine density in limited DNA resources.

Mill J, Yazdanpanah S, G├╝ckel E, Ziegler S, Kaminsky Z, Petronis A.

Biotechniques. 2006 Nov;41(5):603-7.

Supplemental Content

Loading ...
Support Center